Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.

The British journal of dermatology - 17 Oct 2024

Wobser Marion, Appenzeller Silke, Roth Sabine, Siedel Claudia, Goebeler Matthias, Geissinger Eva, Rosenwald Andreas, Maurus Katja

Abstract excerpt

BACKGROUND: Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder (TLPD) is a rare and indolent lymphoma entity. Although TLPD was first identified many years ago, the molecular pathogenesis is still not fully understood. OBJECTIVES: In order to better understand the molecular pathogenesis of cutaneous acral CD8+ TLPD and to identify further discriminatory markers to differentiate this lymphoma subtype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Exome Sequencing

Share to Lymphoma, T-Cell, Cutaneous

Share to Mutation

Share to Receptors, KIR3DL1

Share to Skin Neoplasms

Source

Identifiers

PMID: 38924750
DOI: 10.1093/bjd/ljae256

Genes

KIR3DL1
CD68

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.PMID 38924750Read ↗

Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphomaSemantic proximity Read ↗

Cutaneous Lymphoproliferative Disorders: What's New in the Revised 4th Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms.Semantic proximity Read ↗

Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights and Evolving Treatment ParadigmsSemantic proximity Read ↗

Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative DisorderSemantic proximity Read ↗

Whole-genome profiling of primary cutaneous anaplastic large cell lymphomaSemantic proximity Read ↗

Genetics Abnormalities with Clinical Impact in Primary Cutaneous LymphomasSemantic proximity Read ↗

Updates in pathobiological aspects of anaplastic large cell lymphomaSemantic proximity Read ↗

Molecular pathogenesis of cutaneous lymphoma-Future directions.Semantic proximity Read ↗

Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.Semantic proximity Read ↗

Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders.Semantic proximity Read ↗

Genetic profiles and clinical features in subcutaneous panniculitis-like T-cell lymphomas.Semantic proximity Read ↗

Lessons learned from gene expression profiling of cutaneous T-cell lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.